GENERIC DRUGS

Nowadays Galizen has more than 25 common generic drugs in its catalogue, and can easily supply drugs not listed therein and desired by the client.

The main advantages of the generic drugs within our product range are:

-      WHO-GMP Certificate (World Health Organization Good Manufacturing Practice), which allows sales in Asia, South America (except Brazil, Colombia and Argentina), C.I.S. Countries and Africa.

-      ISO 9001:2000 Certificate.

-      Packing and quantities tailored to individual customer needs.

-      Leaflets, presentations and texts are available in a variety of languages.

-      Ability to sell generic drugs in bulk.

-      Drugs not listed can be acquired according to customer needs.

-      Galizen have the COPP Certificates for the following drugs (see data sheets attached):

If you are interested in purchasing any of the other generic drugs in our catalogue the estimated time to obtain records and complete formalities to prepare for export is between 15 and 45 days.

ACTIVE INGREDIENT COMMERCIAL NAME PRESENTATION INDICATIONS
GLUCOSAMINE GLUCOSAMIZEN 750 Mgr. Capsules or 1500 Mgr. Tablets. Capsules are also available in HDPE bottles of 1000. Relief of symptoms and treatment of knee osteoarthritis (mild to moderate).
FOLIC ACID ACIFOLIZEN 5 Mgr. Tablets. Also available in HDPE bottles of 1000. Prevention and treatment of folic acid deficiency in pregnant women to prevent miscarriage and “neural tube defects”, birth defects such as spina bifida that occur when the fetus’s spine and back don’t close during development. Treatment of folic acid deficiency in processes coursing as megaloblastic anemia, alcoholism, malabsorption syndrome.
DICLOFENAC DICLOFENAZEN 100 Mgr. Sustained Released Capsules. Also available in HDPE bottles of 1000. Treatment of inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism. Painful post-traumatic and post-operative inflammation and swelling. Primary dysmenorrhoea.
AZITHROMYCIN AZITROMYZEN 250 or 500 Mgr. Tablets. Both available in HDPE bottles of 1000. Germ infection sensitive to azithromycin. Upper respiratory tract infection: sinusitis, pharyngitis / strep throat. Lower respiratory tract infections: bronchitis, community-acquired pneumonia of mild to moderately severe. Infection of skin and soft tissue. Acute otitis media. Sexually transmitted diseases: uncomplicated urethritis and cervicitis caused by Chlamydia trachomatis, chancroid (discard conjunction with T. pallidum infection).
CIPROFLOXACIN CIFLOCZEN 250 or 500 Mgr. Tablets. Both available in HDPE bottles of 1000. Lower respiratory tract infections due to Gram-negative bacteria, exacerbations of chronic obstructive pulmonary disease, broncho-pulmonary infections in cystic fibrosis or in bronchiectasis, pneumonia, chronic suppurative otitis media, acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria.
DOMPERIDONE DOMPERIDOZEN 10 Mgr. Tablets.  Also available in HDPE bottles of 1000. The relief of the symptoms of nausea and vomiting, epigastric sense of fullness, upper abdominal discomfort and regurgitation of gastric contents.
ONDANSETRON ONDANSETROZEN 4 Mgr. Tablets. Also available in HDPE bottles of 1000. Control of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. Prevention and treatment of postoperative nausea and vomiting.
ESOMEPRAZOLE OPRAZOZEN 40 Mgr. Capsules. Also available in HDPE bottles of 1000. Gastroesophageal Reflux Disease (GERD), treatment of erosive reflux esophagitis, healing of Helicobacter pylori associated duodenal ulcer, prevention and healing of gastric and duodenal ulcers associated with NSAID therapy, prolonged treatment after i.v. induced prevention of rebleeding of peptic ulcers, treatment of Zollinger Ellison Syndrome.
LORATADINE LORATADIZEN 10 Mgr. Tablets. Also available in HDPE bottles of 1000. Symptomatic and temporary relief of allergic processes due to pollen, pets, dust or other agents. Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.
TRAMADOL TRADOLZEN 50 Mgr. Capsules. Also available in HDPE bottles of 1000.  The treatment of moderate to severe pain.
METRONIDAZOLE METRONIDAZEN 250 Mgr. Tablets. Urethritis and trichomonas vaginalis. Lambliasis. Intestinal and hepatic amoebiasis. Infection by anaerobic bacterias: bacteroides, fusobacterium, eubacteria, clostridium, anaerobic streptococci. Prevention of postoperative infection by anaerobic bacterias, especially bacteroides and streptococci. Warning: It should be administered during meals.
CLOTRIMAZOLE VAGINAL CLOTRIMAZEN VAGINAL 100 o 200 Mgr. Vaginal Tablets. Treatment of single or mixed vaginal infection. Oral coadjuvant treatment of trichomoniasis. Treatment of candidiasic balanitis.
AMLOPIDINE AMLOPIDIZEN 5 or 10 Mgr. Tablets. Both available in HDPE bottles of 1000. Amlodipine is used in the management of hypertension and coronary artery disease.
LOSARTAN OSARTAZEN 25 or 50 Mgr. Tablets. Both available in HDPE bottles of 1000. Treatment of essential hypertension in adults and in children and adolescents 6-18 years of age. Losartan may be administered with other antihypertensive agents, especially with diuretics (e.g. hydrochlorothiazide). Use in patients with intravascular volume depletion. Treatment of chronic heart failure in adult patients when treatment with Angiotensin converting enzyme (ACE) inhibitors is not considered suitable due to incompatibility, especially cough, or contraindication. Patients with heart failure who have been stabilised with an ACE inhibitor should not be switched to losartan. The patients should have a left ventricular ejection fraction ≤ 40% and should be clinically stable and on an established treatment regimen for chronic heart failure. Reduction in the risk of stroke in adult hypertensive patients with left ventricular hypertrophy documented by ECG.
ATENOLOL ATENOLOZEN 25, 50 or 100 Mgr. Tablets. All available in HDPE bottles of 1000. Atenolol belongs to a group of medicines called beta-blockers. It is used to control high blood pressure, relieve chest pain (angina pectoris), control irregular heart beat, protect the heart in the early treatment after a heart attack.
GLIMEPIRIDE GLIMEPIRIZEN 1 or 2 Mgr. Tablets. Both available in HDPE bottles of 1000. Glimepiride is used along with diet and exercise, and sometimes with other medications, to treat type 2 II Diabetes Mellitus.
ATORVASTATIN LIPOTOZEN 10 or 20 Mgr. Tablets.  Both available in HDPE bottles of 1000. Reduce the risk of myocard infarction. Reduce the risk of stroke. Reduce the risk for revascularization procedures and angina. Hyperlipidemia.
SILDENAFIL CITRATE ZORZAZEN 100 Mgr. Tablets. Also available in HDPE bottles of 1000. Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance. In order to be effective, sexual stimulation is required.
CETIRIZINE TO BE DEFINED 100 Mgr. Tablets. Also available in HDPE bottles of 1000. Treatment  for seasonal and perennial allergic rhinitis and urticaria (in adults and children > 2 years).
OFLOXACIN TO BE DEFINED 200 or 400 Mgr. Both available in HDPE bottles of 1000. In the adult population ofloxacin is limited to the treatment of proven serious and life threatening bacterial infections such as: acute bacterial exacerbations of chronic bronchitis, community-acquired pneumonia, uncomplicated skin and skin structure infections, nongonococcal urethritis and cervicitis, mixed infections of the urethra and cervix, acute pelvic inflammatory disease, uncomplicated cystitis, complicated urinary tract infections, prostatitis and acute, uncomplicated urethral and cervical gonorrhea.
LEVOCETIRIZINE TO BE DEFINED 5 Mgr. Tablets. Also available in HDPE bottles of 1000. Symptomatic treatment of allergic rhinitis (including persistent rhinitis) and urticaria.
PIOGLITAZONE TO BE DEFINED 15 or 30 Mgr. Tablets. Both available in HDPE bottles of 1000. Pioglitazone is indicated as second or third line in the treatment of type 2 diabetes mellitus as described: as monotherapy (adults): in adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance. As dual oral therapy in combination with metformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin. A sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea. As triple oral therapy in combination with metformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy. Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance.
TELMISARTAN TO BE DEFINED 20, 40 or 80 Mgr. Tablets. All available in HDPE bottles of 1000. Essential hypertension. Cardiovascular prevention: reduction of cardiovascular morbidity in patients with: a) Manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral cardiovascular disease). b) Type II Diabetes mellitus with documented target organ damage.
ROSUVASTATIN TO BE DEFINED 5, 10 or 20 Mgr. Tablets. All available in HDPE bottles of 1000. Adults, adolescents and children≥ 10 years with primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to diet when response to diet and exercise is inadequate. Homozygous familial hypercholesterolaemia as an adjunct to diet and other lipid-lowering treatments (eg, LDL apheresis). Prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event as an adjunct to correction of other risk factors.

CEPHALOSPORINS:

Nowadays Galizen has 47 cephalosporins in its catalogue, and can easily supply cephalosporins not listed therein and desired by the client.

The main advantages of the cephalosporins within our product range are:

-        WHO-GMP Certificate (World Health Organization Good Manufacturing Practice), which allows sales in Asia, South America (except Brazil, Colombia and Argentina), C.I.S. Countries and Africa. Cephalosporins will be soon UE-GMP Certified (European Union Good Manufacturing Practice) for free sales in EU (except United Kingdom).

-        ISO 14001:2004 Certificate.

-        BS OHSAS 18001:2007 Certificate.

-      Packing and quantities tailored to individual customer needs.

-      Leaflets, presentations and texts are available in a variety of languages.

-      Ability to sell cephalosporins in bulk.

-      Drugs not listed can be acquired according to customer needs.

-      Galizen have the COPP Certificates for the following cephalosporins (see data sheets attached):

If you are interested in purchasing any of the other cephalosporins in our catalogue the estimated time to obtain records and complete formalities to prepare for export is between 15 and 45 days.

ACTIVE INGREDIENT COMMERCIAL NAME PRESENTATION INDICATIONS
CEFUROXIME CEFUROXIZEN SODIUM 750 Mgr. or 1.500 Mgr. Powder for injection (+/- water for injection). Available in bulk. For the treatment of the following conditions caused by susceptible organisms: lower respiratory tract infections, including pneumonia, urinary tract infections, skin and skin-structure infections, septicemia, meningitis, gonorrhea, bone and joint infections caused by Staphylococcus.
CEFTRIAXONE CEFTRIZEN SODIUM 1.000 Mgr. Powder for injection (+/- water for injection). Available in bulk. Infections caused by pathogens sensitive to Ceftriaxone: respiratory tract infections, particularly pneumonia, and ear, nose and thorat infections, renal and urinary tract infections, sepsis, meningitis, abdominal infections (peritonitis, infection of the biliary and gastrointestinal tracts), infections of the bones, joints, soft tissue, skin and of wounds, infections in patients with impaired defence mechanisms, genital infections (including gonorrhoea), perioperative prophylaxis.
CEFOTAXIME  CEFOTAZEN 1.000 Mgr. Powder for injection (+/- water for injection). Available in bulk. Used in the treatment of severe infections caused by Cefotaxime-sensitive pathogens such as: infections of the respiratory tract, including throat and nose, infections of the ear, kidneys and urinary tract infections, skin and soft tissue infections, conditions of the bones and joints, infections in the genital organs and abdominal region, septicaemia, bacterial endocarditis & meningitis. For preoperative prophylaxis in patients who are at increased risk from infection and for the prophylaxis of infections in patients with reduced resistance. Combined treatment: in severe, life-threatening infections, the combination of Cefotaxime Sodium with aminoglycosides is indicated without awaiting the results of sensitivity tests. The two preparations must be administered separately, not mixed in one syringe of infusion bottle. Infections with Pseudomonas aeruginosa may require treatment with other antibiotics effective against Pseudomonas.
CEFAZOLIN CEFAZOZEN 1.000 Mgr. Powder for injection (+/- water for injection). Available in bulk. For the treatment of the following infections due to susceptible organisms: respiratory tract infections, urinary tract infections, skin and skin structure infections, biliary tract infections, bone and joint infections, genital infections, septicemia, endocarditis. Perioperative Prophylaxis: the prophylactic administration of Cefazolin preoperatively, intraoperatively, and postoperatively may reduce the incidence of certain postoperative infections in patients undergoing surgical procedures which are classified as contaminated or potentially contaminated (e.g. vaginal hysterectomy, and cholecystectomy in high-risk patients such as those older than 70 years, with acute cholecystitis, obstructive jaundice, or common duct bile stones). The perioperative use of Cefazolin may also be effective in surgical patients in whom infection at the operative site would present a serious risk (e.g. during open-heart surgery and prosthetic arthroplasty). The prophylactic administration of Cefazolin should usually be discontinued within a 24-hour period after the surgical procedure. In surgery where the occurrence of infection may be particularly devastating (e.g. open-heart surgery and prosthetic arthroplasty), the prophylactic administration of Cefazolin may be continued for 3 to 5 days following the completion of surgery.
CEFTIZOXIME ZOXIZEN 1.000 Mgr. Powder for injection (+/- water for injection). Available in bulk. ZOXIZEN is indicated in the treatment of infections due to susceptible strains of the microorganisms: lower respiratory tract infections, urinary tract infections, pelvic inflammatory disease, intra-abdominal infections, septicemia, skin and skin structure infections, bone and joint infections, meningitis.
CEFTAZIDIME TAZIDIZEN 1.000 Mgr. Powder for injection (+/- water for injection). Serious infections (septicemia, bacteraemia, peritonitis, meningitis); infections in immunosuppressed patients; respiratory tract infections including lung infections in cystic fibrosis; ear, nose and throat infections; urinary tract infections; skin and soft tissue infections; gastrointestinal, biliary and abdominal infections; bone and joint infections; infections associated with haemo and peritoneal dialysis and with continuous ambulatory peritoneal dialysis (CAPD).
CEFOPERAZONE PERAZOZEN 1.000 Mgr. Powder for injection (+/- water for injection). Cefoperazone is indicated for the treatment of the following infections when caused by susceptible organisms: respiratory tract infections, peritonitis and other intra-abdominal infections, bacterial septicemia, infections of the skin and skin structures, pelvic inflammatory disease, endometritis, and other infections of the female genital tract, urinary tract infections, enterococcal infections.
CEFPIROME CEFPIROZEN 1.000 Mgr. Powder for injection (+/- water for injection). Lower respiratory tract infections, bronchopneumonia, lobar pneumonia; complicated upper (pyelonephritis) and lower urinary tract infections; skin and soft tissue infections; bacteraemia/septicaemia.
CEFEPIME CEFEPIZEN 1.000 Mgr. Powder for injection (+/- water for injection). Available in bulk. Pneumonia, empiric therapy for febrile neutropenic patients, uncomplicated and complicated urinary tract infections (including pyelonephritis), uncomplicated skin and skin structure infections, complicated intra-abdominal infections (used in combination with metronidazole), septicaemia.
CEFTRIAXONE AND TAZOBACTAM ZOSIZEN 1000 + 125 Mgr. Powder for injection. Lower respiratory tract infection, skin and skin structure infections, urinary tract infections, gynecological infections, intra-abdominal infections.
CEFTRIAXONE AND SULBACTAM TRIAXULZEN 250 + 125 Mgr. or 1.000 + 500 Mgr. Powder for injection. Surgical prophylaxis, intra-abdominal infections, uncomplicated respiratory infections, gynecological infections.
CEFOPERAZONE AND SULBACTAM PERSULZEN 500 + 500 Mgr or 1.000 + 1.000 Mgr. Powder for injection. Sulbactam/Cefoperazone is indicated for the treatment of the following infections when caused by susceptible organisms: respiratory tract infections (Upper and Lower), urinary tract infections (Upper and Lower), peritonitis, cholecystitis, cholangitis, and other intra-abdominal infections, septicemia, meningitis, skin and soft tissue infections, bone and joint infections, pelvic inflammatory disease, endometritis, gonorrhea, and other infections of the genital tract. Combination therapy: because of the broad spectrum of activity of sulbactam/cefoperazone, most infections can be treated adequately with there antibiotic alone.
CEPHALEXIN CEPHALEXIZEN 500 Mgr. Capsules or 125mgr/5ml (30ml) Oral Suspension. Both available in bulk. Cephalexin is indicated for the treatment of the following infections when caused by susceptible strains: respiratory tract infections, otitis media, skin and skin structure infections, bone infections, genitourinary tract infections, including acute prostatitis, gynecological infections. Cephalexin may be used to treat a number of other bacterial infections.
CEFADROXIL CEFADROXIZEN 500 Mgr. Capsules Treatment of patients with infection caused by susceptible strains of the designated organisms in the following diseases: urinary tract infections caused by E. Coli, P. Mirabilis and Klebsiella species, skin and skin structure infections caused by staphylococci and/or streptococci, pharyngitis and/or tonsillitis caused by Streptococcus pyogenes (Group A beta-hemolytic streptococci). Cefadroxil monohydrate is generally effective in the eradication of streptococci from the oropharynx. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefadroxizen-500 capsules and other antibacterial drugs, Cefadroxizen Capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria.
CEFDINIR CEFDIZEN 300 Mgr. Capsules or 125 mgr/5ml (30ml) Oral Suspension. Respiratory tract infections (Upper and Lower), community-acquired pneumonia, pharyngitis, otitis, bronchitis, sinusitis, skin and soft tissue infections.
CEFACLOR CEFACLOZEN 250 Mgr. Capsules. Available in bulk. CEFACLOZEN is indicated in the treatment of the following infections when caused by susceptible strains of micro-organisms: lower respiratory infections, acute bronchitis, and acute exacerbations of chronic bronchitis, upper respiratory infections, including pharyngitis and tonsillitis (Note: penicillin is the usual medicine of choice in the treatment and prevention of streptococcal), infections, including the prophylaxis of rheumatic fever, otitis media, skin and soft-tissue infections, urinary tract infections (Note: Cefaclor has been found to be effective in both acute and chronic urinary tract infections), skin and skin structure infections, sinusitis.
CEFPODOXIME CEFOTAXIZEN 100 or 200 Mgr. Tablets/Capsules or 50mgr/5ml (30ml) Oral Suspension Recurrent and chronic tonsillitis, pharyngitis, sinusitis and acute otitis media, acute bronchitis, bacterial pneumonia, lower respiratory infection; uncomplicated urinary tract infections, pyelonephritis, uncomplicated gonococcal urethritis and skin and soft-tissue infections.
CEPHRADINE CEFRADIZEN 250 Mgr. Capsules. It is prescribed in the treatment of certain infections caused by susceptible bacterial strains causing respiratory, genitourinary, gastrointestinal, skin and soft tissue, and bone and joint infections, or septicemia, osteoarticular infection, endocarditis and meningitis-N. meningitidis.
CEFUROXIME AXETIL CEFUROXIZEN AX 250 or 500 Mgr. Tablets. Also available in 125mgr/5ml (30ml) Oral Suspension. It is prescribed in the treatment of certain infections caused by susceptible strains: upper respiratory tract infections (otitis media, sinusitis, pharyngitis/tonsillitis caused by S. pyogenes), lower respiratory trac infections (acute bronchitis, community-acquired pneumonia, infected bronchiectasis, lung abscess and post operative chest infections), urinary tract infections, skin and soft tissue infections, gonorrhoea (when penicillin is contraindicated), septicemia.
CEFIXIME CEFIXIZEN 100 or 200 Mgr. Tablets. Also available in 50mgr/5ml (30ml) or 100mgr/5ml (30ml) Oral Suspension. Also available in 100 Mgr. Sachets. Pharyngitis/tonsillitis caused by S. pyogenes, acute bronchitis, exacerbation of chronic bronchitis and pneumonia caused by B. catarrhalis, S. pneumoniae and H. influenzae. Otitis media and acute sinusitis caused by H. influenzae, B. catarrhalis, S. pyogenes and S. pneumoniae. Uncomplicated tract infection caused by E. coli and P. mirabilis.
WARNING:

Generic Drugs promoted by GALIZEN are matched to WHO-GMP Standards, which do not allow its sale within the EU or USA.

GALIZEN´s activity is not dedicated to individuals and our main customers are distributors and traders within the medical and health industry, as well as hospitals, health centers, laboratories and companies, both public and private, engaged in the sale, manufacture and distribution of health related products worldwide, being a basic condition, the compliance with the Law on health in the country concerned. Galizen may require to these companies all information and documentation to verify compliance with the Law.



Warning: require_once(/homepages/6/d419627521/htdocs/galizen/wp-content/themes/wpheal/footer.php) [function.require-once]: failed to open stream: Permission denied in /homepages/6/d419627521/htdocs/galizen/wp-includes/template.php on line 407

Fatal error: require_once() [function.require]: Failed opening required '/homepages/6/d419627521/htdocs/galizen/wp-content/themes/wpheal/footer.php' (include_path='.:/usr/lib/php5.2:/homepages/6/d419627521/htdocs/galizen/wp-content/plugins/updraftplus/includes/phpseclib') in /homepages/6/d419627521/htdocs/galizen/wp-includes/template.php on line 407